-
Advisers to the Food and Drug Administration supported boosters of the Pfizer-BioNTech COVID-19 vaccine for a smaller group of people after they voted against recommending it for anyone 16 and older.
-
The Texas Poison Center has received 260 calls with ivermectin poisoning. Ivermectin is a livestock dewormer, and people are using it to prevent or treat a coronavirus infection.
-
The approval replaces the emergency use authorizations granted last December and could make it easier for employers, the military and universities to mandate vaccination.
-
The FDA amended its emergency use authorizations for the Pfizer and Moderna vaccines to allow for an additional dose for some immunocompromised people.
-
Moderna dijo que presentará los resultados de sus estudios más recientes a la Administración de Alimentos y Medicamentos y otros reguladores globales en junio.
-
Moderna said it will submit the results of its study to the Food and Drug Administration and regulators in other countries next month.
-
The company said in late March that clinical trials showed the vaccine elicits "100% efficacy and robust antibody responses" in adolescents.
-
The Food and Drug Administration is working on a playbook for how it could greenlight vaccine tweaks. Studies in hundreds of people, rather than tens of thousands, seem likely.
-
Advisers to the Food and Drug Administration voted 20-0 to recommend that the agency authorize Moderna's vaccine for emergency use during the pandemic. There was a single abstention.
-
The new tests produce results completely at home within 15 minutes. Experts say they could be a 'game-changer' in helping people find out quickly if they need to isolate.